Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER Meeting Abstract
| Authors: | Wu, C.; Strickler, J. H.; Cercek, A.; Siena, S.; André, T.; Ng, K.; Van Cutsem, E.; Paulson, A. S.; Hubbard, J.; Coveler, A.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Elez Fernandez, M. E.; Hsu, L. I.; Stecher, M.; Zhao, K.; Bekaii-Saab, T. |
| Abstract Title: | Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S700 |
| End Page: | S701 |
| Language: | English |
| ACCESSION: | WOS:000866211600355 |
| DOI: | 10.1016/j.annonc.2022.07.499 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 361P -- Source: Wos |
